Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A

被引:261
作者
Fauman, EB [1 ]
Cogswell, JP
Lovejoy, B
Rocque, WJ
Holmes, W
Montana, VG
Piwnica-Worms, H
Rink, MJ
Saper, MA
机构
[1] Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA
[3] Glaxo Wellcome Inc, Dept Funct Genet, Res Triangle Pk, NC 27709 USA
[4] Glaxo Wellcome Inc, Dept Struct Chem, Res Triangle Pk, NC 27709 USA
[5] Glaxo Wellcome Inc, Dept Mol Sci, Res Triangle Pk, NC 27709 USA
[6] Washington Univ, Sch Med, Dept Cell Biol & Physiol, Howard Hughes Med Inst, St Louis, MO 63110 USA
关键词
D O I
10.1016/S0092-8674(00)81190-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cdc25 phosphatases activate the cell division kinases throughout the cell cycle. The 2.3 Angstrom structure of the human Cdc25A catalytic domain reveals a small alpha/beta domain with a fold unlike previously described phosphatase structures but identical to rhodanese, a sulfur-transfer protein. Only the active-site loop, containing the Cys-(X)(5)-Arg motif, shows similarity to the tyrosine phosphatases. In some crystals, the catalytic Cys-430 forms a disulfide bond with the invariant Cys-384, suggesting that Cdc25 may be self-inhibited during oxidative stress. Asp-383, previously proposed to be the general acid, instead serves a structural role, forming a conserved buried salt-bridge. We propose that Glu-431 may act as a general acid. Structure-based alignments suggest that the noncatalytic domain of the MAP kinase phosphatases will share this topology, as will ACR2, a eukaryotic arsenical resistance protein.
引用
收藏
页码:617 / 625
页数:9
相关论文
共 52 条
  • [1] [Anonymous], [No title captured]
  • [2] The PROSITE database, its status in 1997
    Bairoch, A
    Bucher, P
    Hofmann, K
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (01) : 217 - 221
  • [3] CRYSTAL-STRUCTURE OF HUMAN PROTEIN-TYROSINE-PHOSPHATASE 1B
    BARFORD, D
    FLINT, AJ
    TONKS, NK
    [J]. SCIENCE, 1994, 263 (5152) : 1397 - 1404
  • [4] Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization
    Bilwes, AM
    denHertog, J
    Hunter, T
    Noel, JP
    [J]. NATURE, 1996, 382 (6591) : 555 - 559
  • [5] Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO
  • [6] 2-Y
  • [7] Sequential dephosphorylation of p34(cdc2) on Thr-14 and Tyr-15 at the prophase/metaphase transition
    Borgne, A
    Meijer, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) : 27847 - 27854
  • [8] SLOW-COOLING PROTOCOLS FOR CRYSTALLOGRAPHIC REFINEMENT BY SIMULATED ANNEALING
    BRUNGER, AT
    KRUKOWSKI, A
    ERICKSON, JW
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1990, 46 : 585 - 593
  • [9] Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34
  • [10] A CATALYTIC MECHANISM FOR THE DUAL-SPECIFIC PHOSPHATASES
    DENU, JM
    DIXON, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) : 5910 - 5914